DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals 
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand 
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales 
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List 
Amazon Stock Dips Despite Record Earnings as AI Infrastructure Spending Surges 
Ford Q1 Earnings Beat Expectations, Stock Surges on Strong Guidance 
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S. 
Advantest Stock Falls on Weak Outlook Despite Strong AI-Driven Results 
TSMC Exits Arm Holdings with $231 Million Share Sale Amid Strategic Portfolio Shift 
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook 
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector 
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales 
Starbucks Raises 2026 Outlook as Turnaround Strategy Boosts Sales and Earnings 
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds 
Qualcomm Stock Surges Despite Weak Guidance After Q2 2026 Earnings Beat 
Standard Chartered Q1 Profit Hits Record on Wealth and Investment Banking Growth 
WOBURN, Mass., April 26, 2017 -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that the Company plans to release its first quarter 2017 financial results and host a conference call with management after market close on Thursday, May 11, 2017.
Shareholders will participate in the call in listen-only mode. The Company invites shareholders to submit questions for consideration by May 5, 2017 to [email protected] with the subject line: “Questions for First Quarter 2017 Call.” Questions submitted in advance of the call will be reviewed and some will be addressed in management's prepared remarks or in the Q&A portion of the call.
Interested participants can join the conference call using the following numbers:
| U.S. Toll-free dial-in: | 1-877-709-8150 | |
| International dial-in: | 201-689-8354 | |
| Event Date/Time: | Thursday, May 11 at 4:30 p.m. EDT |
A live webcast of the call including the slide deck can be accessed through the investor relations section of the Company’s website at www.yield10bio.com. The webcast will be archived on the Company’s website in the investor relations section.
To listen to a telephonic replay of the conference call, dial 877-660-6853 (toll-free) or 201-612-7415 (international) and enter passcode 13658898. The replay will be available for 14 days.
About Yield10
Yield10 Bioscience, Inc. is focused on developing new technologies to achieve step-change improvements in crop yield to enhance global food security. Yield10 is leveraging an extensive track record of innovation based around optimizing the flow of carbon in living systems. By working on new approaches to improve fundamental elements of plant photosynthetic efficiency and optimizing seed production, Yield10 is advancing several yield traits it has developed in crops such as Camelina, canola, soybean and corn. Yield10 is based in Woburn, MA.
For more information about the Company, please visit www.yield10bio.com.
(YTEN-E)
Contacts: Yield10 Bioscience: Lynne H. Brum, (617) 682-4693, [email protected] Investor Relations Contact: Amato and Partners, LLC 90 Park Avenue, 17th Floor New York, NY 10016 [email protected]
